Where can I find more detail on the CAPTAIN study?
Relative to other studies investigating triple therapy in asthma, CAPTAIN inclusion criteria were intentionally broadened to capture the heterogeneity of uncontrolled…
The CAPTAIN study provides robust evidence to support, and better tailor, the use of triple therapy using a treatable-traits-based approach. In this section you will find more information on how the CAPTAIN study supports the use of triple therapy in asthma.
Asthma Forward is a registered trademark of the GSK group of companies.
©2023 GSK group of companies. All rights reserved.
SE-GBL-FVU-WCNT-200010 | Date of preparation: October 2023